Apollo Hospitals Enterprise Limited — Board Meeting, 12-08-2025: Outcome of Board Meeting

Apollo Hospitals announced its Q1 FY26 consolidated results: Revenue at Rs. 5,842 Cr (+15% YoY), EBITDA at Rs. 852 Cr (+26% YoY), and PAT at Rs. 433 Cr (+42% YoY).

The Board approved acquiring the remaining 50% stake in Apollo Gleneagles PET-CT for Rs. 8.5 Cr, making it a wholly-owned diagnostics subsidiary to boost integration. The strategic demerger of the Omni-channel pharmacy and digital health business into Apollo Healthtech Limited, approved previously, is now in implementation phase, aiming to unlock value. Looking ahead, the company plans to add over 4,300 beds in the next 5 years with an investment exceeding Rs. 7,600 Cr, signaling strong expansion. Apollo 24/7's GMV for the quarter reached Rs. 682 Cr, highlighting digital growth.